By continuing to use our site, you agree to our Terms of Use and Privacy Policy. You can learn more about how we use cookies by reviewing our Privacy Policy.

I Agree

Archive for May, 2015

Lumos Pharma Receives Wellcome Trust Award for Advancing Potental Treatment of Creatine Transporter Deficiency (CTD)

AUSTIN, Texas – May 4th, 2015 – Lumos Pharma, Inc. (Austin, Texas) announced today that it has received an award of up to $5.5 million from the Translation Fund of the Wellcome Trust. CEO of Lumos Pharma, Richard Hawkins, stated “We are very pleased Wellcome Trust has selected Lumos for an award and we are privileged...Read More